156 related articles for article (PubMed ID: 36210700)
1. [DNAM-1 regulates the proliferation and function of T regulatory type 1 cells
Wang N; Wang Y; Jiang P; Lü M; Hu Z; Xu X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1288-1295. PubMed ID: 36210700
[TBL] [Abstract][Full Text] [Related]
2. CD226 deficiency attenuates the homeostasis and suppressive capacity of Tr1 cells.
Wang N; Chen P; Song Y; Shen Y; Li J; Li X; Fang L; Chen L
Mol Immunol; 2021 Apr; 132():192-198. PubMed ID: 33451863
[TBL] [Abstract][Full Text] [Related]
3. CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.
Sutavani RV; Bradley RG; Ramage JM; Jackson AM; Durrant LG; Spendlove I
J Immunol; 2013 Dec; 191(12):5895-903. PubMed ID: 24198281
[TBL] [Abstract][Full Text] [Related]
4. The role of STAT3 and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells.
Liu X; Hu H; Fan H; Zuo D; Shou Z; Liao Y; Nan Z; Tang Q
Medicine (Baltimore); 2017 Apr; 96(17):e6615. PubMed ID: 28445259
[TBL] [Abstract][Full Text] [Related]
5. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
6. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
7. Suppression of allogeneic T cells proliferation by CD3/CD46-induced T-regulatory 1 cells.
Chen D; Zhang Y; Li M; Zhang C; Chen G; Chen Z; Chen S; Zhang W
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):332-6. PubMed ID: 20556577
[TBL] [Abstract][Full Text] [Related]
8. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
9. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.
Levings MK; Sangregorio R; Galbiati F; Squadrone S; de Waal Malefyt R; Roncarolo MG
J Immunol; 2001 May; 166(9):5530-9. PubMed ID: 11313392
[TBL] [Abstract][Full Text] [Related]
11. Decreased regulatory function of CD4
Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
13. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
14. The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Toraya T; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
J Immunol; 2008 Sep; 181(6):3897-905. PubMed ID: 18768844
[TBL] [Abstract][Full Text] [Related]
15. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
Wang R; Huang K
Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
[TBL] [Abstract][Full Text] [Related]
16. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.
Narayan S; Kolly L; So A; Busso N
Immunology; 2011 Sep; 134(1):33-40. PubMed ID: 21718313
[TBL] [Abstract][Full Text] [Related]
18. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
19. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3.
Owaki T; Asakawa M; Kamiya S; Takeda K; Fukai F; Mizuguchi J; Yoshimoto T
J Immunol; 2006 Mar; 176(5):2773-80. PubMed ID: 16493033
[TBL] [Abstract][Full Text] [Related]
20. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
June CH; Ledbetter JA; Gillespie MM; Lindsten T; Thompson CB
Mol Cell Biol; 1987 Dec; 7(12):4472-81. PubMed ID: 2830495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
